Results 191 to 200 of about 106,894 (260)

Apple Pomace Pectin for Gastroprotective Nutraceutical Delivery: Structure–Function Relationships and Nano/Microencapsulation Strategies for Gastric Ulcer Management

Food Frontiers, Volume 7, Issue 4, July 2026.
Apple pomace pectin is explored as a sustainable and multifunctional biomaterial for gastric ulcer management. Its unique structural features confer mucoadhesive, anti‐inflammatory, antioxidant, and anti‐Helicobacter pylori activities while enabling nano/microencapsulation of therapeutic agents.
Akash Dhiman, Shefali Arora, Parteek Prasher, Sukanya Chhetri, Pankaj Bhandari, William N. Setzer, Javad Sharifi‐Rad   +6 more
wiley   +1 more source

Trends in Unprotected Left Main Percutaneous Coronary Intervention and Clinical Outcomes.

JAMA Netw Open
Ikemura N, Mori Y, Chan PS, Cohen DJ, Yamaji K, Amano T, Kozuma K, Spertus JA, Kohsaka S.   +8 more
europepmc   +1 more source

Difference in outcomes between right and left posterior descending artery percutaneous coronary intervention: an Australian statewide registry analysis. [PDF]

Egypt Heart J
Rahman Zahin M, Batchelor R, Brennan A, Dinh D, Reid C, Stub D, Lefkovits J.   +6 more
europepmc   +1 more source

Association of Global Longitudinal Strain With Left Ventricular Remodeling and Left Ventricular Hypertrophy in Patients With Acute Myocardial Infarction After PCI: A Small Single‐Center Prospective Observational Study

Health Science Reports, Volume 9, Issue 7, July 2026.
ABSTRACT Background and Aims Among patients with acute myocardial infarction undergoing PCI, subsequent structural alterations of the left ventricle, including left ventricular remodeling (LVR) and left ventricular hypertrophy (LVH), may contribute to later heart failure.
Bing Wang, Hong Yao, Zhijian Zhu, Zhigang Lu, Yesheng Pan   +4 more
wiley   +1 more source

Radiation-Free Percutaneous Coronary Intervention: Myth or Reality? [PDF]

J Cardiovasc Dev Dis
Kotoulas SC, Triantafyllis AS, Kontogiannis N, Tsinivizov P, Antoniades K, Aqeel I, Karapedi E, Kolyda A, Poulimenos LE.   +8 more
europepmc   +1 more source

Regulatory Challenges and Opportunities for Cell‐Derived Extracellular Vesicles in Pharmaceutical Development: A European and Global Perspective

Journal of Extracellular Vesicles, Volume 15, Issue 7, July 2026.
EV‐based therapeutics are advancing worldwide, but regulatory classification and development expectations remain inconsistent across jurisdictions. This review maps challenges in quality, potency, comparability, safety, clinical design, and ethical/legal oversight, and argues for consistent use of existing medicinal‐product frameworks. We emphasize the
Tania Limongi, Paola Milla, Barbara Stella, Silvia Arpicco   +3 more
wiley   +1 more source

Optical coherence tomography-guided percutaneous coronary intervention compared to angiography-guided percutaneous coronary intervention for complex lesions. [PDF]

World J Cardiol
Burhan M, Saeed H, Usama M, Tariq A, Shafiq S, Hurjkaliani S, Iqbal M, Shahid S, Khalid S, Tahirkheli NK.   +9 more
europepmc   +1 more source

Ischemia–Reperfusion Injury: Molecular Mechanisms and Therapeutic Interventions

MedComm, Volume 7, Issue 7, July 2026.
Multiorgan ischemia–reperfusion injury begins with ischemia‐induced ATP depletion and ionic imbalance, followed by reperfusion‐triggered mitochondrial ROS/RNS bursts, regulated cell death, and DAMP release. Sterile inflammation converges on endothelial–immune–coagulation crosstalk, where NETs drive immunothrombosis, no‐reflow, and remote organ injury ...
Peng An, Yi An, Mengwei Chen, Longlong Wu, Rong Wang   +4 more
wiley   +1 more source

Value of Color Doppler Echocardiography for Predicting Heart Failure After Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction. [PDF]

Int J Gen Med
Ren L, Hu Z, Huang Z, Xu L.
europepmc   +1 more source

Health‐Related Quality of Life and Associated Factors Among Patients With Bioprosthetic Heart Valve Replacement: A Cross‐Sectional Study

Nursing Open, Volume 13, Issue 7, July 2026.
ABSTRACT Aim The use of bioprosthetic heart valves has significantly increased in recent years due to the aging population and advances in technology. Health‐related quality of life (HRQoL) is as important as clinical outcomes. However, little is known about the long‐term HRQoL of patients after bioprosthetic heart valve replacement and its ...
Yun‐xia Ni, Yan‐lin Ye, Huang Feng, Zhi Li, Chao‐yi Qin, Miao Chen   +5 more
wiley   +1 more source